-
HRP Goat Anti-Rabbit IgG in Nerve Repair Research
2026-09-24
Affinity-Purified Goat Anti-Rabbit IgG (H+L) can support rigorous protein detection when researchers investigate lactate-driven macrophage changes after peripheral nerve injury. This article connects recent nerve-regeneration findings to practical assay choices, controls, and interpretation—not just antibody selection.
-
FDA-Approved Library Screening for MERS-CoV Inhibitors
2026-09-24
A screen of 348 FDA-approved compounds identified chloroquine, chlorpromazine, loperamide, and lopinavir as cell-culture inhibitors of MERS-CoV replication, with reported EC50 values in the low-micromolar range. The study established a repurposing lead set and evidence of activity across additional coronaviruses, while leaving efficacy in animals or patients and the compounds’ molecular targets unresolved.
-
Acetylspiramycin: From Ribosome to Translation
2026-09-23
Acetylspiramycin, also known as Spiramycin B, offers translational researchers a useful bridge between ribosomal mechanism, antimicrobial resistance research, assay design, and host-response biology. This article outlines how to position the compound in reproducible susceptibility workflows while avoiding overinterpretation of in vitro activity.
-
Acetylspiramycin: Workflows for Resistance Studies
2026-09-23
Acetylspiramycin (Spiramycin B) gives researchers a defined 16-membered macrolide input for susceptibility testing, ribosome-focused experiments, and host–pathogen models. This guide connects practical solvent handling and broth microdilution with resistance benchmarking, pathway-engineering insights, and immune-modulation controls.
-
Blebbistatin Workflows for Spatial Cell Mechanics
2026-09-22
Use (±)-Blebbistatin to convert migration, adhesion, and morphology imaging into reversible tests of non-muscle myosin II function. A spatially registered workflow, inspired by multimodal cardiac mapping, helps separate local cytoskeletal effects from broad changes in cell health or image appearance.
-
Netarsudil: From ROCK Biology to siRNA Translation
2026-09-21
Netarsudil (AR-13324) offers a useful translational bridge between ROCK biology, trabecular meshwork cell modulation, and predictive siRNA codelivery. This article explains the mechanistic rationale, interprets recent validation data, and outlines a disciplined workflow for moving from cytoskeletal assays to formulation and ocular translation.
-
S63845 MCL1 Inhibitor: Applied Research Guide
2026-09-21
S63845 is a selective MCL1 inhibitor for mapping mitochondrial apoptosis, prioritizing MCL1-dependent hematological models, and testing residual disease after chemotherapy-induced senescence. This guide converts its nanomolar binding profile into practical dosing, validation, troubleshooting, and comparative assay strategies.
-
SB 431542: ALK5 Inhibitor Workflow for Fibrosis
2026-09-20
Use SB 431542 to separate TGF-β receptor signaling from downstream PI3K/AKT effects in fibrosis, cancer, and immune-cell assays. This workflow combines the reference study’s 10 μM A549-cell model with practical controls, phospho-Smad2 readouts, and troubleshooting guidance for reproducible pathway inhibition.
-
RESTRICT-seq maps SCC resistance dependencies
2026-09-19
The preprint introduces RESTRICT-seq, a time-gated CRISPR screening strategy designed to distinguish genetic dependencies that initiate, maintain, or emerge during squamous cell carcinoma resistance. Its identification of epigenetic regulators including KAT6A provides a framework for studying resistance-associated senescence and for prioritizing mechanistically defined follow-up experiments.
-
Sulfisomidine: From Pertussis Data to Assay Design
2026-09-19
Sulfisomidine, also known as sulfamethin, offers a valuable bridge between historical exposure data and modern biochemical assay design. This article interprets the pertussis study as a lesson in matrix control, concentration measurement, and responsible translation across antibacterial and hPON1 research.
-
Epacadostat (INCB024360): IDO1 Assay Guide
2026-09-18
This scenario-driven guide explains how Epacadostat (INCB024360), SKU B6036, can help researchers separate IDO1-mediated immunometabolic effects from nonspecific cytotoxicity in cell and whole-blood assays. It provides practical guidance on solvent controls, dose interpretation, orthogonal readouts, and evidence-based product selection.
-
Standardized Whole-Blood Stimulation in Immunometabolism
2026-09-18
Zhao and colleagues present a standardized whole-blood stimulation protocol that combines innate immune challenges with targeted metabolic interventions. The design preserves the complexity of human blood while enabling reproducible analysis of cytokines and metabolism-dependent immune responses across cohorts.
-
FCCP: From Mitochondrial Stress to Translational Insight
2026-09-17
FCCP converts mitochondrial uncoupling into a controllable experimental lens for studying oxidative phosphorylation, HIF signaling, metabolic phenotypes, and autophagy-oriented discovery workflows.
-
Baicalein Workflows for Cancer and Inflammation
2026-09-17
Baicalein enables controlled interrogation of 12-LOX, apoptosis, inflammatory signaling, and cancer-cell responses in cell-free and cellular assays. This practical workflow also shows how to pair oncology experiments with neurotoxicity models without assuming that results from formononetin automatically apply to Baicalein.
-
Aminopeptidase Inhibitors in Next-Generation Cancer Therapy
2026-09-16
The reference review positions aminopeptidases as downstream regulators of proteasome-derived peptide processing, antigen presentation, and amino-acid recycling, connecting their dysregulation to cancer biology. Its central contribution is a mechanistic framework for evaluating established agents such as Bestatin alongside newer inhibitors, combination regimens, and resistance mechanisms.